Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy

References

• Silva CT, Mateus H, Contreras N. Restrepo CM Distrofia muscular de Duchenne y Becker: una visión molecular. Acta Med Colomb. 2005;3(30):112–116.
   Google Scholar
• Bernal J, Obando F. La carga de la enfermedad genética en Colombia, 1996-2025. Universitas Médica. 2007;49:12–28.
   Google Scholar
• Mercuri E, Bonnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394(10213):2025–2038.
   PubMed Web of Science ®Google Scholar
• Waldrop MA, Flanigan KM. Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019;32(5):722–727. doi:10.1097/WCO.0000000000000739
   PubMed Web of Science ®Google Scholar
• Gao QQ, McNally EM. The Dystrophin complex: structure, function, and implications for therapy. Compr Physiol. 2015;5(3):1223–1239. doi:10.1002/cphy.c140048
   PubMed Web of Science ®Google Scholar
• Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992;355(6362):696–702. doi:10.1038/355696a355690
   Web of Science ®Google Scholar
• Le Rumeur E. Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies. Bosnian J Basic Med Sci. 2015;15(3):14–20. doi:10.17305/bjbms.12015.17636
   Web of Science ®Google Scholar
• Bladen CL, Salgado D, Monges S, et al. The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36(4):395–402. doi:10.1002/humu.22758
   PubMed Web of Science ®Google Scholar
• Mah JK, Selby K, Campbell C, et al. A population-based study of dystrophin mutations in Canada. Can J Neurol Sci. 2011;38(3):465–474. doi:10.1017/S0317167100011896
   PubMed Web of Science ®Google Scholar
• Aravind S, Ashley B, Mannan A, et al. Targeted sequencing of the DMD locus: a comprehensive diagnostic tool for all mutations. Indian J Med Res. 2019;150(3):282–289. doi:10.4103/ijmr.IJMR_4290_4118
   Web of Science ®Google Scholar
• Polavarapu K, Preethish-Kumar V, Sekar D, et al. Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort. J Neurol. 2019;266(9):2177–2185. doi:10.1007/s00415-00019-09380-00413
   Web of Science ®Google Scholar
• Tian PC, Wang Y, Shi DD, Chen Z, Luo Q, Wang HL. [Application of next-generation sequencing in the molecular diagnosis of Duchenne muscular dystrophy]. Zhongguo Dang Dai Er Ke Za Zhi/Chinese J Contemporary Pediatrics. 2019;21(3):244–248. Chinese.
   Google Scholar
• Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, et al. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS One. 2015;10(8):e0135189. doi:10.0131371/journal.pone.0135189
   PubMed Web of Science ®Google Scholar
• Deburgrave N, Daoud F, Llense S, et al. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat. 2007;28(2):183–195. doi:10.1002/humu.20422
   Web of Science ®Google Scholar
• Muntoni F, Desguerre I, Guglieri M, et al. Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry. J Comp Eff Res. 2019;8(14):1187–1200. doi:10.2217/cer-2019-0086
   PubMed Web of Science ®Google Scholar
• Nakamura A. Mutation-based therapeutic strategies for Duchenne Muscular Dystrophy: from genetic diagnosis to therapy. J Personalized Med. 2019;9(1):16. doi:10.3390/jpm9010016
   Web of Science ®Google Scholar
• Luce L, Carcione M, Mazzanti C, et al. Theragnosis for Duchenne muscular dystrophy. Front Pharmacol. 2021;12:648390. doi:10.3389/fphar.2021.648390
   PubMed Web of Science ®Google Scholar
• Elhawary NA, Jiffri EH, Jambi S, et al. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community. Hum Genomics. 2018;12(1):18. doi:10.1186/s40246-40018-40152-40248
   Web of Science ®Google Scholar
• Vieitez I, Gallano P, Gonzalez-Quereda L, et al. Mutational spectrum of Duchenne muscular dystrophy in Spain: study of 284 cases. Neurol. 2017;32(6):377–385. doi:10.1016/j.nrl.2015.1012.1009
   Web of Science ®Google Scholar
• Magri F, Del Bo R, D’Angelo MG, et al. Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing. BMC Med Genet. 2011;12:37. doi:10.1186/1471-2350-1112-1137
   Web of Science ®Google Scholar
• Silva CT, Fonseca DJ, Mateus H, Contreras N, Restrepo C. Deleciones en el gen de la distrofina en 62 familias colombianas: correlación genotipo-fenotipo para la distrofia muscular de Duchenne y Becker. Colomb Med. 2009;35:191–198.
   Google Scholar
• Vieitez I, Gallano P, Gonzalez-Quereda L, et al. Mutational spectrum of Duchenne muscular dystrophy in Spain: study of 284 cases. Neurol. 2017;32(6):377–385. doi:10.1016/j.nrl.2015.12.009
   Web of Science ®Google Scholar
• Chen C, Ma H, Zhang F, et al. Screening of Duchenne muscular dystrophy (DMD) mutations and investigating its mutational mechanism in Chinese patients. PLoS One. 2014;9(9):e108038. doi:10.1371/journal.pone.0108038
   Web of Science ®Google Scholar
• Manjunath M, Kiran P, Preethish-Kumar V, Nalini A, Singh RJ, Gayathri N. A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study. Neurol India. 2015;63(1):58–62. doi:10.4103/0028-3886.152635
   Web of Science ®Google Scholar
• Okubo M, Minami N, Goto K, et al. Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Human Genetics. 2016;61(6):483. doi:10.1038/jhg.2016.1037
   Web of Science ®Google Scholar
• Zhou J, Xin J, Niu Y, Wu S. DMDtoolkit: a tool for visualizing the mutated dystrophin protein and predicting the clinical severity in DMD. BMC Bioinform. 2017;18(1):87. doi:10.1186/s12859-017-1504-4
   Web of Science ®Google Scholar
• Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2(1):90–95. doi:10.1016/0888-7543(1088)90113-90119
   PubMed Web of Science ®Google Scholar
• Gurvich OL, Maiti B, Weiss RB, Aggarwal G, Howard MT, Flanigan KM. DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6. Hum Mutat. 2009;30(4):633–640. doi:10.1002/humu.20913
   Web of Science ®Google Scholar
• Wang Z, Lin Y, Qiu L, et al. Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype. Clin Chem Lab Med. 2016;54(9):1435–1440. doi:10.1515/cclm-2015-1042
   Web of Science ®Google Scholar
• Flanigan KM, Dunn DM, von Niederhausern A, et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat. 2009;30(12):1657–1666. doi:10.1002/humu.21114
   PubMed Web of Science ®Google Scholar
• Mohammed F, Elshafey A, Al-Balool H, et al. Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: the era of personalized medicine. PLoS One. 2018;13(5):e0197205. doi:10.1371/journal.pone.0197205
   Web of Science ®Google Scholar
• Bladen CL, Salgado D, Monges S, et al. The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36(4):395–402. doi:10.1002/humu.22758
   PubMed Web of Science ®Google Scholar
• Tuffery-Giraud S, Béroud C, Leturcq F, et al. Genotype-phenotype analysis in 2405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat. 2009;30(6):934–945. doi:10.1002/humu.20976
   PubMed Web of Science ®Google Scholar
• Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, et al. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS One. 2015;10(8):e0135189. doi:10.1371/journal.pone.0135189
   PubMed Web of Science ®Google Scholar
• de Almeida PAD, Machado-Costa MC, Manzoli GN, et al. Genetic profile of Brazilian patients with dystrophinopathies. Clin Genet. 2017;92(2):199–203. doi:10.1111/cge.12975
   Web of Science ®Google Scholar
• Ramos E, Conde JG, Berrios RA, Pardo S, Gómez O, Mas Rodríguez MF. Prevalence and genetic profile of Duchene and Becker muscular dystrophy in Puerto Rico. J Neuromusc Dis. 2016;3(2):261–266. doi:10.3233/JND-160147
   Google Scholar
• López-Hernández LB, Gómez-Díaz B, Luna-Angulo AB, et al. Comparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies. Int J Mol Sci. 2015;16(3):5334–5346. doi:10.3390/ijms16035334
   Web of Science ®Google Scholar
• Huamán-Dianderas FD, Guevara-Fujita ML, Málaga DR, Estrada-Cuzcano A, Fujita R. [Detection of mutations causing Duchenne and Becker muscular dystrophies: multiplex polymerase chain reaction vs. Multiplex ligation dependent probe amplification]. Rev Peru Med Exp Salud Publica. 2019;36(3):475–480. Catalan.
   Google Scholar
• Delgado Luengo W, Pineda-Del Villar L, Borjas L, et al. Molecular diagnosis of Duchenne/Becker muscular dystrophy in Venezuelan patients with the polymerase chain reaction. Invest Clin. 1994;35(4):195–207.
   Google Scholar
• Adhikari K, Mendoza-Revilla J, Chacón-Duque JC, Fuentes-Guajardo M, Ruiz-Linares A. Admixture in Latin America. Curr Opin Genet Dev. 2016;41:106–114. doi:10.1016/j.gde.2016.09.003
   PubMed Web of Science ®Google Scholar
• Salzano FM, Sans M. Interethnic admixture and the evolution of Latin American populations. Genet Mol Biol. 2014;37(1 Suppl):151–170. doi:10.1590/S1415-47572014000200003
   PubMed Web of Science ®Google Scholar
• De Castro M, Restrepo CM. Genetics and genomic medicine in Colombia. Mol Genetics Genomic Med. 2015;3(2):84–91. doi:10.1002/mgg3.139
   Web of Science ®Google Scholar
• Selvatici R, Rossi R, Fortunato F, Trabanelli C, Sifi Y. Ethnicity-related DMD genotype landscapes in European and non-European countries. Neurol Genetics. 2021;7(1):e536.
   Web of Science ®Google Scholar
• Laing NG, Davis MR, Bayley K, Fletcher S, Wilton SD. Molecular diagnosis of Duchenne muscular dystrophy: past, present and future in relation to implementing therapies. Clin Biochem Rev. 2011;32(3):129–134.
   PubMedGoogle Scholar
• Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet. 2016;53(3):145–151. doi:10.1136/jmedgenet-2015-103387
   PubMed Web of Science ®Google Scholar
• Sun C, Shen L, Zhang Z, Xie X. Therapeutic strategies for Duchenne muscular dystrophy: an update. Genes. 2020;11:8. doi:10.3390/genes11080837
   Web of Science ®Google Scholar
• Muntoni F, Desguerre I, Guglieri M, et al. Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry. J Comp Eff Res. 2019;8(14):1187–1200. doi:10.2217/cer-2019-0086
   PubMed Web of Science ®Google Scholar
• Peltz SW, Morsy M, Welch EM, Jacobson A. Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med. 2013;64:407–425. doi:10.1146/annurev-med-120611-144851
   PubMed Web of Science ®Google Scholar
• Stein CA, Castanotto D. FDA-approved oligonucleotide therapies in 2017. Mol Ther. 2017;25(5):1069–1075. doi:10.1016/j.ymthe.2017.03.023
   PubMed Web of Science ®Google Scholar
• Heo YA. Golodirsen: first approval. Drugs. 2020;80(3):329–333. doi:10.1007/s40265-020-01267-2
   PubMed Web of Science ®Google Scholar
• Charleston JS, Schnell FJ, Dworzak J, et al. Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production. Neurology. 2018;90(24):2146–2154. doi:10.1212/WNL.0000000000005680
   PubMed Web of Science ®Google Scholar
• Brusa R, Magri F, Bresolin N, Comi GP, Corti S. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives. Cell Mol Life Sci. 2020;77(21):4299–4313. doi:10.1007/s00018-020-03537-4
   Web of Science ®Google Scholar
• Chemello F, Bassel-Duby R, Olson EN. Correction of muscular dystrophies by CRISPR gene editing. J Clin Invest. 2020;130(6):2766–2776. doi:10.1172/JCI136873
   Web of Science ®Google Scholar